GPD1L 抗体 (AA 1-351)
Our Local Distributor
北京 101111
Quick Overview for GPD1L 抗体 (AA 1-351) (ABIN5776141)
抗原
See all GPD1L 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 1-351
-
原理
- Human GPD1L antibody
-
纯化方法
- Purified
-
免疫原
- Recombinant human GPD1L (1-351aa) purified from E. coli
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C,-80 °C
-
储存方法
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))
-
别名
- GPD1L
-
背景
- GPD1L is converts sn-glycerol 3-phosphate to glycerone phosphate. This protein is found in the cytoplasm, associated with the plasma membrane, where it binds the sodium channel, voltage-gated, type V, alpha subunit (SCN5A). GPD1L is thought to affect trafficking of the cardiac sodium current to the cell surface. Mutations in GPD1L are the cause of sudden infant death syndrome (SIDS) and Brugada syndrome type 2, an autosomal dominant tachyarrhythmia.
-
NCBI登录号
- NP_055956
抗原
-